{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:37:14Z","timestamp":1785681434198,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidad de C\u00f3rdoba"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We present the clinicopathological features of 23 cases of the giant cell subtype of urothelial carcinoma, a rare subtype of bladder cancer recognized in the current World Health Organization classification of urological tumors. Histologically, the architectural pattern of the tumor varied from infiltrating to the solid expansile pleomorphic tumor with giant, bizarre, anaplastic cells. Typical or atypical mitotic figures were frequently present in all cases. Between 10 and 30% of the tumor had a giant cell component. All cases were associated with conventional high-grade urothelial carcinoma, with areas of squamous cell divergent differentiation and micropapillary carcinoma present in six and two cases, respectively. In one case each had sarcomatoid, nested, small cell, or glandular divergent differentiation. At diagnosis, 35% of patients had advanced disease and 12% had distant metastases. When comparing giant cell urothelial carcinoma with conventional urothelial carcinoma in a matched analysis, differences in overall and cancer-specific survival were observed, particularly in the T1 stage category. Immunohistochemical staining showed a similar profile of urothelial lineage with frequent positive expression of uroplakin II, GATA3, CK20, CK7, and S100P in both giant cell and conventional urothelial carcinomas. High Ki67 proliferation (range, 60\u201390%; mean, 71%) and nuclear p53 accumulation (mutant profile; range, 50\u201390%; mean, 64%) were observed. Using the 22C3 assay, the expression of PD-L1 was found to be variable in two cases, and beta-HCG was negative. In conclusion, giant cell carcinoma is a subtype of urothelial carcinoma associated with advanced clinical stage and a trend to lower survival rates.<\/jats:p>","DOI":"10.1007\/s00428-024-03858-w","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T04:01:36Z","timestamp":1721275296000},"page":"535-546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Giant cell carcinoma of the urinary bladder"],"prefix":"10.1007","volume":"485","author":[{"given":"Frederico","family":"Portugal-Gaspar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-8164","authenticated-orcid":false,"given":"Antonio","family":"Lopez-Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladell P.","family":"Paner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Blanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique G\u00f3mez","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cimadamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Bil\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metka","family":"Volav\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"3858_CR1","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-838","volume-title":"WHO classification of tumours series: urinary and male genital tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board (2022) WHO classification of tumours series: urinary and male genital tumours. International Agency for Research on Cancer, Lyon (France). https:\/\/doi.org\/10.32074\/1591-951X-838"},{"key":"3858_CR2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.humpath.2009.02.016","volume":"40","author":"A Lopez-Beltran","year":"2009","unstructured":"Lopez-Beltran A, Blanca A, Montironi R, Cheng L, Regueiro JC (2009) Pleomorphic giant cell carcinoma of the urinary bladder. Hum Pathol 40:1461\u20131466. https:\/\/doi.org\/10.1016\/j.humpath.2009.02.016","journal-title":"Hum Pathol"},{"key":"3858_CR3","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/PAS.0000000000002077","volume":"48","author":"GP Paner","year":"2024","unstructured":"Paner GP, Kamat A, Netto GJ, Samaratunga H, Varma M, Bubendorf L, van der Kwast TH, Cheng L, Members of the ISUP Bladder Tumor Consensus Panel (2024) International Society of Urological Pathology (ISUP) consensus conference on current issues in bladder cancer. Working Group 2: Grading of mixed grade, invasive urothelial carcinoma including histologic subtypes and divergent differentiations, and non-urothelial carcinomas. Am J Surg Pathol 48:e11\u2013e23. https:\/\/doi.org\/10.1097\/PAS.0000000000002077","journal-title":"Am J Surg Pathol"},{"key":"3858_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/his.12785","volume":"68","author":"H Samaratunga","year":"2016","unstructured":"Samaratunga H, Delahunt B, Egevad L, Adamson M, Hussey D, Malone G, Hoyle K, Nathan T, Kerle D, Ferguson P, Nacey JN (2016) Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de-differentiation. Histopathology 68:533\u2013540. https:\/\/doi.org\/10.1111\/his.12785","journal-title":"Histopathology"},{"key":"3858_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/PAT.0b013e3283560172","volume":"44","author":"H Samaratunga","year":"2012","unstructured":"Samaratunga H, Delahunt B (2012) Recently described and unusual variants of urothelial carcinoma of the urinary bladder. Pathology 44:407\u2013418. https:\/\/doi.org\/10.1097\/PAT.0b013e3283560172","journal-title":"Pathology"},{"key":"3858_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/cancers13010131","volume":"13","author":"A Lopez-Beltran","year":"2021","unstructured":"Lopez-Beltran A, Cimadamore A, Blanca A, Massari F, Vau N, Scarpelli M, Cheng L, Montironi R (2021) Immune checkpoint inhibitors for the treatment of bladder cancer. Cancers (Basel) 13:131. https:\/\/doi.org\/10.3390\/cancers13010131","journal-title":"Cancers (Basel)"},{"key":"3858_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00428-018-2394-1","volume":"473","author":"V Barresi","year":"2018","unstructured":"Barresi V (2018) HOXB13 is not expressed in pleomorphic giant cell carcinoma of the bladder. Virchows Arch 473:259\u2013260. https:\/\/doi.org\/10.1007\/s00428-018-2394-1","journal-title":"Virchows Arch"},{"key":"3858_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.17140\/UAOJ-4-133","volume":"4","author":"A Vega-Vega","year":"2020","unstructured":"Vega-Vega A, Simpson F, Samaratunga H, Vega-Garcia A (2020) Pleomorphic giant cell carcinoma of urinary bladder with brain metastases despite initial response to cisplatin and gemcitabine: a case report. Urol Androl Open J 4:46\u201350. https:\/\/doi.org\/10.17140\/UAOJ-4-133","journal-title":"Urol Androl Open J"},{"key":"3858_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1440-1827.2008.02218.x","volume":"58","author":"M Yasunaga","year":"2008","unstructured":"Yasunaga M, Ohishi Y, Nishimura I, Tamiya S, Iwasa A, Takagi E, Inoue T, Yahata H, Kobayashi H, Wake N, Tsuneyoshi M (2008) Ovarian undifferentiated carcinoma resembling giant cell carcinoma of the lung. Pathol Int 58:244\u2013248. https:\/\/doi.org\/10.1111\/j.1440-1827.2008.02218.x","journal-title":"Pathol Int"},{"key":"3858_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00428-020-02745-4","volume":"477","author":"I Rolim","year":"2020","unstructured":"Rolim I, Henriques V, Rolim N, Blanca A, Marques RC, Volavsek M, Carvalho I, Montironi R, Cimadamore A, Raspollini MR, Cheng L, Lopez-Beltran A (2020) Clinicopathologic analysis of upper urinary tract carcinoma with variant histology. Virchows Arch 477:111\u2013120. https:\/\/doi.org\/10.1007\/s00428-020-02745-4","journal-title":"Virchows Arch"},{"key":"3858_CR11","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/00000478-200309000-00003","volume":"27","author":"G Pelosi","year":"2003","unstructured":"Pelosi G, Fraggetta F, Nappi O, Pastorino U, Maisonneuve P, Pasini F, Iannucci A, Solli P, Musavinasab HS, De Manzoni G, Terzi A, Viale G (2003) Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility: a clinicopathologic and immunohistochemical study of 31 cases. Am J Surg Pathol 27:1203\u20131215. https:\/\/doi.org\/10.1097\/00000478-200309000-00003","journal-title":"Am J Surg Pathol"},{"key":"3858_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1097\/01.pas.0000209841.77595.4b","volume":"30","author":"AV Parwani","year":"2006","unstructured":"Parwani AV, Herawi M, Epstein JI (2006) Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases. Am J Surg Pathol 30:1254\u20131259. https:\/\/doi.org\/10.1097\/01.pas.0000209841.77595.4b","journal-title":"Am J Surg Pathol"},{"key":"3858_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/PAP.0b013e31817d79b9","volume":"15","author":"P Nigwekar","year":"2008","unstructured":"Nigwekar P, Amin MB (2008) The many faces of urothelial carcinoma: an update with an emphasis on recently described variants. Adv Anat Pathol 15:218\u2013233. https:\/\/doi.org\/10.1097\/PAP.0b013e31817d79b9","journal-title":"Adv Anat Pathol"},{"key":"3858_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5858\/2000-124-0135-PGCCOT","volume":"124","author":"JF Mosnier","year":"2000","unstructured":"Mosnier JF, Balique JG (2000) Pleomorphic giant cell carcinoma of the esophagus with coexpression of cytokeratin and vimentin and neuroendocrine differentiation. Arch Pathol Lab Med 124:135\u2013138. https:\/\/doi.org\/10.5858\/2000-124-0135-PGCCOT","journal-title":"Arch Pathol Lab Med"},{"key":"3858_CR15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1440-1827.2007.02159.x","volume":"57","author":"T Lenicek","year":"2007","unstructured":"Lenicek T, Szerda F, Demirovic A, Mijic A, Kruslin B, Tomas D (2007) Pleomorphic ductal carcinoma of the breast with predominant micropapillary features. Pathol Int 57:694\u2013697. https:\/\/doi.org\/10.1111\/j.1440-1827.2007.02159.x","journal-title":"Pathol Int"},{"key":"3858_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2147\/OTT.S150124","volume":"11","author":"X Li","year":"2018","unstructured":"Li X, Zhang Z, Liu J, Wang D, Wei S, Chen J (2018) Molecular features of giant-cell carcinoma of the lung: a case report and literature review. Onco Targets Ther 11:751\u2013756. https:\/\/doi.org\/10.2147\/OTT.S150124","journal-title":"Onco Targets Ther"},{"key":"3858_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00428-022-03481-7","volume":"482","author":"A Bile-Silva","year":"2023","unstructured":"Bile-Silva A, Lopez-Beltran A, Rasteiro H, Vau N, Blanca A, Gomez E, Gaspar F, Cheng L (2023) Pleomorphic giant cell carcinoma of the prostate: clinicopathologic analysis and oncological outcomes. Virchows Arch 482:493\u2013505. https:\/\/doi.org\/10.1007\/s00428-022-03481-7","journal-title":"Virchows Arch"},{"key":"3858_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/030089169107700615","volume":"77","author":"RA Caruso","year":"1991","unstructured":"Caruso RA, Famulari C, Giuffre G, Mazzeo G (1991) Pleomorphic carcinoma of the gallbladder: report of a case. Tumori 77:523\u2013526. https:\/\/doi.org\/10.1177\/030089169107700615","journal-title":"Tumori"},{"key":"3858_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00428-021-03264-6","volume":"480","author":"A Lopez-Beltran","year":"2022","unstructured":"Lopez-Beltran A, Blanca A, Cimadamore A, Montironi R, Luque RJ, Volavsek M, Cheng L (2022) T1 bladder carcinoma with variant histology: pathological features and clinical significance. Virchows Arch 480:989\u2013998. https:\/\/doi.org\/10.1007\/s00428-021-03264-6","journal-title":"Virchows Arch"},{"key":"3858_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/PAS.0b013e3181cd385b","volume":"34","author":"A Lopez-Beltran","year":"2010","unstructured":"Lopez-Beltran A, Amin MB, Oliveira PS, Montironi R, Algaba F, McKenney JK, de Torres I, Mazerolles C, Wang M, Cheng L (2010) Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Am J Surg Pathol 34:371\u2013376. https:\/\/doi.org\/10.1097\/PAS.0b013e3181cd385b","journal-title":"Am J Surg Pathol"},{"key":"3858_CR21","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1097\/PAS.0b013e3182159dec","volume":"35","author":"L Cheng","year":"2011","unstructured":"Cheng L, Zhang S, Alexander R, Maclennan GT, Hodges KB, Harrison BT, Lopez-Beltran A, Montironi R (2011) Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation. Am J Surg Pathol 35:e34\u2013e46. https:\/\/doi.org\/10.1097\/PAS.0b013e3182159dec","journal-title":"Am J Surg Pathol"},{"key":"3858_CR22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1097\/00005392-199805000-00023","volume":"159","author":"A Lopez-Beltran","year":"1998","unstructured":"Lopez-Beltran A, Pacelli A, Rothenberg HJ, Wollan PC, Zincke H, Blute ML, Bostwick DG (1998) Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol 159:1497\u20131503. https:\/\/doi.org\/10.1097\/00005392-199805000-00023","journal-title":"J Urol"},{"key":"3858_CR23","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/PAS.0000000000000254","volume":"38","author":"MB Amin","year":"2014","unstructured":"Amin MB, Epstein JI, Ulbright TM, Humphrey PA, Egevad L, Montironi R, Grignon D, Trpkov K, Lopez-Beltran A, Zhou M, Argani P, Delahunt B, Berney DM, Srigley JR, Tickoo SK, Reuter VE, Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group (2014) Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference. Am J Surg Pathol 38:1017\u20131022. https:\/\/doi.org\/10.1097\/PAS.0000000000000254","journal-title":"Am J Surg Pathol"},{"key":"3858_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.5858\/2005-129-0683-PGCCOT","volume":"129","author":"A Lopez-Beltran","year":"2005","unstructured":"Lopez-Beltran A, Eble JN, Bostwick DG (2005) Pleomorphic giant cell carcinoma of the prostate. Arch Pathol Lab Med 129:683\u2013685. https:\/\/doi.org\/10.5858\/2005-129-0683-PGCCOT","journal-title":"Arch Pathol Lab Med"},{"key":"3858_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","volume":"38","author":"M Miettinen","year":"2014","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z (2014) GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 38:13\u201322. https:\/\/doi.org\/10.1097\/PAS.0b013e3182a0218f","journal-title":"Am J Surg Pathol"},{"key":"3858_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.humpath.2020.01.004","volume":"98","author":"M Akgul","year":"2020","unstructured":"Akgul M, MacLennan GT, Cheng L (2020) The applicability and utility of immunohistochemical biomarkers in bladder pathology. Hum Pathol 98:32\u201355. https:\/\/doi.org\/10.1016\/j.humpath.2020.01.004","journal-title":"Hum Pathol"},{"key":"3858_CR27","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.humpath.2012.12.012","volume":"44","author":"A Chang","year":"2013","unstructured":"Chang A, Brimo F, Montgomery EA, Epstein JI (2013) Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma. Hum Pathol 44:1563\u20131568. https:\/\/doi.org\/10.1016\/j.humpath.2012.12.012","journal-title":"Hum Pathol"},{"key":"3858_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/PAP.0000000000000150","volume":"24","author":"M Suryavanshi","year":"2017","unstructured":"Suryavanshi M, Sanz-Ortega J, Sirohi D, Divatia MK, Ohe C, Zampini C, Luthringer D, Smith SC, Amin MB (2017) S100P as a marker for urothelial histogenesis: a critical review and comparison with novel and traditional urothelial immunohistochemical markers. Adv Anat Pathol 24:151\u2013160. https:\/\/doi.org\/10.1097\/PAP.0000000000000150","journal-title":"Adv Anat Pathol"},{"key":"3858_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.humpath.2014.09.007","volume":"46","author":"W Tian","year":"2015","unstructured":"Tian W, Guner G, Miyamoto H, Cimino-Mathews A, Gonzalez-Roibon N, Argani P, Li X, Sharma R, Subhawong AP, Rezaei K, Bivalacqua TJ, Epstein JI, Bishop JA, Netto GJ (2015) Utility of uroplakin II expression as a marker of urothelial carcinoma. Hum Pathol 46:58\u201364. https:\/\/doi.org\/10.1016\/j.humpath.2014.09.007","journal-title":"Hum Pathol"},{"key":"3858_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/modpathol.3800521","volume":"19","author":"D Baydar","year":"2006","unstructured":"Baydar D, Amin MB, Epstein JI (2006) Osteoclast-rich undifferentiated carcinomas of the urinary tract. Mod Pathol 19:161\u2013171. https:\/\/doi.org\/10.1038\/modpathol.3800521","journal-title":"Mod Pathol"},{"key":"3858_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.clgc.2016.08.027","volume":"15","author":"MF Monn","year":"2017","unstructured":"Monn MF, Jaqua KR, Bihrle R, Cheng L (2017) Primary choriocarcinoma of the bladder: a case report and review of literature. Clin Genitourin Cancer 15:188\u2013191. https:\/\/doi.org\/10.1016\/j.clgc.2016.08.027","journal-title":"Clin Genitourin Cancer"},{"key":"3858_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.path.2018.07.011","volume":"11","author":"H Al-Ahmadie","year":"2018","unstructured":"Al-Ahmadie H, Iyer G (2018) Updates on the genetics and molecular subtypes of urothelial carcinoma and select variants. Surg Pathol Clin 11:713\u2013723. https:\/\/doi.org\/10.1016\/j.path.2018.07.011","journal-title":"Surg Pathol Clin"},{"key":"3858_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/PAP.0000000000000252","volume":"27","author":"H Al-Ahmadie","year":"2020","unstructured":"Al-Ahmadie H, Netto GJ (2020) Updates on the genomics of bladder cancer and novel molecular taxonomy. advances in anatomic pathology 27:36\u201343. https:\/\/doi.org\/10.1097\/PAP.0000000000000252","journal-title":"advances in anatomic pathology"},{"key":"3858_CR34","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.3390\/cancers13215500","volume":"13","author":"A Lopez-Beltran","year":"2021","unstructured":"Lopez-Beltran A, Blanca A, Cimadamore A, Gogna R, Montironi R, Cheng L (2021) Molecular classification of bladder urothelial carcinoma using nanostring-based gene expression analysis. Cancers (Basel) 13:5500. https:\/\/doi.org\/10.3390\/cancers13215500","journal-title":"Cancers (Basel)"},{"key":"3858_CR35","first-page":"S263","volume":"467","author":"H Akkaya","year":"2015","unstructured":"Akkaya H, Ipekci T, Hoscan M, Ozdemir H (2015) Pleomorphic giant cell carcinoma of the urinary bladder: report of two cases. Virchows Arch 467:S263\u2013S264","journal-title":"Virchows Arch"},{"key":"3858_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.prp.2013.01.008","volume":"209","author":"BA Alexiev","year":"2013","unstructured":"Alexiev BA, Papadimitriou JC, Chai TC, Ramos E, Staats PN, Drachenberg CB (2013) Polyomavirus (BK)-associated pleomorphic giant cell carcinoma of the urinary bladder: a case report. Pathol Res Pract 209:255\u2013259. https:\/\/doi.org\/10.1016\/j.prp.2013.01.008","journal-title":"Pathol Res Pract"},{"key":"3858_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.14989\/ActaUrolJap_65_9_377","volume":"65","author":"H Kimura","year":"2019","unstructured":"Kimura H, Uemura Y, Megumi Y, Tachibana M, Fukuzawa S (2019) A case of cT3bN2M0 pleomorphic giant cell carcinoma of the bladder without recurrence after neoadjuvant chemotherapy and radical cystectomy for 4 years. Hinyokika Kiyo 65:377\u2013380. https:\/\/doi.org\/10.14989\/ActaUrolJap_65_9_377","journal-title":"Hinyokika Kiyo"},{"key":"3858_CR38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/iju5.12281","volume":"4","author":"K Nezu","year":"2021","unstructured":"Nezu K, Kakoi N, Tezuka F, Ota S (2021) Successful treatment of metastatic bladder pleomorphic giant cell carcinoma with pembrolizumab. IJU Case Rep 4:200\u2013203. https:\/\/doi.org\/10.1002\/iju5.12281","journal-title":"IJU Case Rep"},{"key":"3858_CR39","doi-asserted-by":"publisher","first-page":"8021947","DOI":"10.1155\/2021\/8021947","volume":"2021","author":"HD Wijesinghe","year":"2021","unstructured":"Wijesinghe HD, Malalasekera A (2021) Giant cell urothelial carcinoma of bladder. Case Rep Urol 2021:8021947. https:\/\/doi.org\/10.1155\/2021\/8021947","journal-title":"Case Rep Urol"},{"key":"3858_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin 67:93\u201399. https:\/\/doi.org\/10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"3858_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/his.13752","volume":"74","author":"A Lopez-Beltran","year":"2019","unstructured":"Lopez-Beltran A, Henriques V, Montironi R, Cimadamore A, Raspollini MR, Cheng L (2019) Variants and new entities of bladder cancer. Histopathology 74:77\u201396. https:\/\/doi.org\/10.1111\/his.13752","journal-title":"Histopathology"},{"key":"3858_CR42","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/14737159.2018.1490179","volume":"18","author":"A Cimadamore","year":"2018","unstructured":"Cimadamore A, Gasparrini S, Santoni M, Cheng L, Lopez-Beltran A, Battelli N, Massari F, Giunchi F, Fiorentino M, Scarpelli M, Montironi R (2018) Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer. Expert Rev Mol Diagn 18:645\u2013655. https:\/\/doi.org\/10.1080\/14737159.2018.1490179","journal-title":"Expert Rev Mol Diagn"},{"key":"3858_CR43","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1200\/JCO.18.01148","volume":"36","author":"A Necchi","year":"2018","unstructured":"Necchi A, Anichini A, Raggi D, Briganti A, Massa S, Luciano R, Colecchia M, Giannatempo P, Mortarini R, Bianchi M, Fare E, Monopoli F, Colombo R, Gallina A, Salonia A, Messina A, Ali SM, Madison R, Ross JS et al (2018) Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study. J Clin Oncol: Offic J Am Soc Clin Oncol 36:3353\u20133360. https:\/\/doi.org\/10.1200\/JCO.18.01148","journal-title":"J Clin Oncol: Offic J Am Soc Clin Oncol"},{"key":"3858_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.eururo.2019.10.026","volume":"77","author":"A Necchi","year":"2020","unstructured":"Necchi A, Raggi D, Gallina A, Madison R, Colecchia M, Luciano R, Montironi R, Giannatempo P, Fare E, Pederzoli F, Bandini M, Bianchi M, Colombo R, Gandaglia G, Fossati N, Marandino L, Capitanio U, Deho F, Ali SM et al (2020) Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies. Eur Urol 77:439\u2013446. https:\/\/doi.org\/10.1016\/j.eururo.2019.10.026","journal-title":"Eur Urol"},{"key":"3858_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/PAS.0000000000001264","volume":"43","author":"H Reis","year":"2019","unstructured":"Reis H, Serrette R, Posada J, Lu V, Chen YB, Gopalan A, Fine SW, Tickoo SK, Sirintrapun SJ, Iyer G, Funt SA, Teo MY, Rosenberg JE, Bajorin DF, Dalbagni G, Bochner BH, Solit DB, Reuter VE, Al-Ahmadie HA (2019) PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: concordance among 3 commonly used and commercially available antibodies. Am J Surg Pathol 43:920\u2013927. https:\/\/doi.org\/10.1097\/PAS.0000000000001264","journal-title":"Am J Surg Pathol"},{"key":"3858_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","volume":"6","author":"N Lobo","year":"2020","unstructured":"Lobo N, Shariat SF, Guo CC, Fernandez MI, Kassouf W, Choudhury A, Gao J, Williams SB, Galsky MD, Taylor JA 3rd, Roupret M, Kamat AM (2020) What is the significance of variant histology in urothelial carcinoma? Eur Urol Focus 6:653\u2013663. https:\/\/doi.org\/10.1016\/j.euf.2019.09.003","journal-title":"Eur Urol Focus"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03858-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03858-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03858-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T09:04:29Z","timestamp":1726823069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03858-w"}},"subtitle":["Clinicopathologic analysis and oncological outcomes"],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3858"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03858-w","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The submitted work was approved by the local ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}